Urologic Oncology (Cancer)
The Department of Urology at UI Health offers the most advanced therapies available for urologic cancers, including open and laparoscopic surgery, robot-assisted surgery, radiation therapy (IGRT and IMRT), chemotherapy and combination therapies.
Our urologic surgeons have expertise in using specialized technologies and minimally invasive surgical techniques for treating urologic cancers. People suffering from renal, bladder, prostate, and testicular cancers can find relief at UI Health.
Renal cancer is a cancer that starts in the lining of very small tubes (tubules) in the kidney. Renal cancer is the most common type of kidney cancer in adults, responsible for approximately 80% of cases. Risk factors for kidney cancer include cigarette smoking, obesity, high blood pressure, and African American race.
Procedures we perform for renal cancer:
- Nephron sparing surgery - removal or ablation of tumors of the kidney while saving the remaining normal kidney
a. Robotic assisted partial nephrectomy (kidney removal)
b. Image guided thermal ablation (freezing or heating) of small kidney tumors
c. Imaging surveillance of kidney tumors
- Vena cava thrombectomy - removal of kidney tumors causing a blood clot in the veins
- Minimally invasive nephrectomy - removal of a kidney containing a tumor or tumors via "mini-incision" surgery
Bladder cancer is a type of cancer that begins in your bladder - a hollow, muscular organ that stores urine. Bladder cancer begins in the lining of the bladder but can grow into the muscle layer. Cigarette smoking is the strongest risk factor for bladder cancer. Other risk factors include exposure to chemicals such as dyes and rubber by-products.
Procedures we perform for bladder cancer:
- Management of recurrent bladder tumors with intravesical therapy - the bladder is filled with medication that prevents recurrence of non-invasive bladder tumors
- Robotic-assisted radical cystectomy - removal of the bladder and surrounding lymph nodes using minimally invasive surgery
- Bladder reconstruction - creating of a new bladder or pouch that allows patients to be continent of urine after bladder removal
Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Prostate cancer is the most common non-skin cancer in men. Prostate cancer begins in the prostate gland, however cancer cells may metastasize (spread) from the prostate to other parts of the body, particularly the bones and lymph nodes. Risk factors for prostate cancer include family history of prostate cancer, African American race, and increasing age.
Procedures we perform for prostate cancer:
- Active surveillance and MRI guided biopsy- using MRI to guide prostate biopsies in order to minimize random biopsy
- Robotic-assisted prostatectomy - removal of the cancerous prostate using the minimally invasive DaVinci robot. The technology allows superior surgeon vision allowing preservation of the erectile nerves.
- Radiation therapy (IMRT, 4D GPS guided radiotherapy) - radiation therapy using GPS technology that adjusts to the movement of the prostate during treatment allowing more accurate targeting.
- Hormonal and chemotherapy
- Cancer survivorship - penile rehabilitation, and treatment of erectile dysfunction and urinary incontinence associated with prostate cancer and its treatment
Testicular cancer occurs in the testicles, which produce male sex hormones and sperm for reproduction. Typically a painless lump is felt in the scrotum. When testicular cancer spreads, the cancer cells are carried by blood or to the lymph nodes in the abdomen. Compared with other types of cancer, testicular cancer is rare. But testicular cancer is the most common cancer in American males between the ages of 15 and 34.
Procedures we perform for testicular cancer:
- Retroperitoneal lymph node dissection - removal of the lymph nodes in the abdomen
- Sperm banking prior to treatment - extraction and storage of sperm prior to chemotherapy
- Cancer survivorship - fertility services and placement of testicular implants after testicle removal
Michael R. Abern MD - Urologic surgery
Ervin Kocjancic MD - Urology cancer survivorship and reconstruction
David Peace MD - Medical Oncology
Arkadiusz Dudek MD, PhD - Medical Oncology and clinical trials
Matt Koshy MD - Radiation Oncology